Medication info
Vastin Tablets 10/20 Milligrams

Vastin Tablets 10/20 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White to off-white, double-convex rectangular tablets
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201600903 · Approved 2016.02.17 · Insurance code 657805760

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking 10/80 mg for 12 months or more without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and monitor closely when administering higher doses to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
View approved original text

This medication is used as an adjunct to diet in patients with primary hypercholesterolemia to help reduce elevated total cholesterol, LDL cholesterol, ApoB protein, and triglycerides, while increasing HDL cholesterol. Particularly in patients with homozygous familial hypercholesterolemia, it is used when other lipid-lowering treatments are not effective or used in conjunction with those treatments. This medication should be taken alongside a proper diet, and potential impacts from other conditions or medications must be confirmed beforehand. Careful consideration is required as a lipid-lowering agent for patients at high risk of cardiovascular disease. Regular blood lipid tests during treatment are important; especially in patients with acute coronary events, measuring lipid levels at the time of hospitalization or within 24 hours post-admission is recommended. Overall, this medication is used effectively to improve hypercholesterolemia and related lipid abnormalities.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, recommended treatment goal, and response. Administer this drug once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. Patients who require less LDL-cholesterol reduction may start at 10/10mg once daily. After starting this drug or adjusting the dose, check blood lipid levels at intervals of 4 weeks or more and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this drug should be used only in patients who have been taking 10/80 mg for 12 months or more without evidence of muscle toxicity (see section 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This drug is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate or severe hepatic impairment (see section 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this drug 10/20mg once daily in the evening. Use caution and monitor closely when administering higher doses to these patients (see section 5. General Precautions under Precautions for Use). Administration in elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other drugs (See section 6. Interactions under Precautions for Use.) Administer this drug at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this drug concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10mg/day of this drug. Patients receiving this drug concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20mg/day of this drug.

Precautions

This medication may cause adverse reactions in muscles, so it is important to immediately inform a doctor if symptoms such as muscle pain or weakness occur. There is a serious risk of muscle damage, including myopathy and rhabdomyolysis, especially when taking high doses, so extra caution is needed. Patients with allergies to any component of this medication, active liver disease, or persistent unexplained elevations in liver enzymes should not take this medication. Women who are pregnant or nursing should not take this medication, and women of childbearing age should confirm pregnancy status before taking it. When taken with strong CYP3A4 inhibitors such as certain antifungals, antibiotics, and HIV medications, the risk of muscle damage greatly increases; therefore, co-administration should be avoided. This medication should also not be taken with gemfibrozil, cyclosporine, or danazol. Elderly patients, those with hypothyroidism, or patients with decreased kidney function have a higher risk of myopathy, so caution is necessary during use. This medication can affect liver function, so patients with liver disease should have regular liver function tests and should consult a doctor immediately if symptoms of liver function abnormalities occur. If any muscle-related symptoms or liver function abnormalities develop, the use of this medication should be discontinued and healthcare personnel should be consulted. Furthermore, this medication may interact with various drugs, so when taking new medications, it is essential to inform healthcare personnel of the use of this medication. Excessive consumption of grapefruit juice may raise the blood concentration of this medication, increasing the risk of side effects. This medication is not recommended for children or those under 10 years of age, as safety and effectiveness have not been adequately established. While taking this medication, blood sugar levels may rise, so patients at risk for diabetes should regularly monitor their blood glucose levels. There is no specific antidote for overdose, so appropriate treatment based on symptoms is necessary.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 105 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reactions with systemic symptoms
  • erythema multiforme
  • liver damage
  • muscle weakness
  • cataracts
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • oculomotor dysfunction
  • facial incomplete paralysis
  • tremors
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disturbances
  • memory impairment
  • forgetfulness
  • amnesia
  • cognitive impairment
  • confusion
  • interstitial lung disease
  • angioedema
  • lupus erythematosus-like syndrome
  • rheumatic polymyalgia
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • lethargy
  • dyspnea
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • liver failure
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • increased bilirubin
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White to off-white, double-convex rectangular tablets

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.